<mods xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" ID="P0b002ee1e230492c">
    <name type="corporate">
         <namePart>United States Government Publishing Office</namePart>
         <role>
              <roleTerm authority="marcrelator" type="text">publisher</roleTerm>
              <roleTerm authority="marcrelator" type="code">pbl</roleTerm>
        </role>
         <role>
              <roleTerm authority="marcrelator" type="text">distributor</roleTerm>
              <roleTerm authority="marcrelator" type="code">dst</roleTerm>
        </role>
    </name>
    <name type="corporate">
         <namePart>United States</namePart>
         <namePart>National Archives and Records Administration</namePart>
         <namePart>Office of the Federal Register</namePart>
         <role>
              <roleTerm authority="marcrelator" type="text">author</roleTerm>
              <roleTerm authority="marcrelator" type="code">aut</roleTerm>
        </role>
         <description>Government Organization</description>
    </name>
    <typeOfResource>text</typeOfResource>
    <genre authority="marcgt">government publication</genre>
    <language>
         <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
    </language>
    <extension>
         <collectionCode>DCPD</collectionCode>
         <category>Budget and Presidential Materials</category>
         <branch>executive</branch>
         <dateIngested>2026-05-28</dateIngested>
    </extension>
    <name type="corporate">
         <namePart>United States</namePart>
         <namePart>Executive Office of the President</namePart>
         <role>
              <roleTerm authority="marcrelator" type="text">originator</roleTerm>
              <roleTerm authority="marcrelator" type="code">org</roleTerm>
        </role>
         <description>United States Government Agency</description>
    </name>
    <name type="personal">
         <namePart>Donald J. Trump</namePart>
         <role>
              <roleTerm authority="marcrelator" type="text">originator</roleTerm>
              <roleTerm authority="marcrelator" type="code">org</roleTerm>
        </role>
         <description>President of the United States</description>
    </name>
    <titleInfo>
         <title>Remarks on Efforts To Reduce Prescription Drug Costs and an Exchange With Reporters</title>
    </titleInfo>
    <location>
         <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/DCPD-202501101</url>
         <url displayLabel="HTML rendition" access="raw object">https://www.govinfo.gov/content/pkg/DCPD-202501101/html/DCPD-202501101.htm</url>
         <url displayLabel="PDF rendition" access="raw object">https://www.govinfo.gov/content/pkg/DCPD-202501101/pdf/DCPD-202501101.pdf</url>
    </location>
    <identifier type="preferred citation">DCPD-202501101</identifier>
    <note>The President spoke at 12:02 p.m. in the Oval Office at the White House. In his remarks, he referred to White House Communications Director Steven Cheung; former President Barack Obama; Jacqueline Emmer, wife of Rep. Emmer; former Secretary of Transportation Peter P.M. Buttigieg; and former Sens. Joseph A. Manchin III and Kyrsten L. Sinema. Administrator Oz referred to John Brooks, Deputy Administrator and Chief Policy and Regulatory Officer, and Inmaculada &quot;Inma&quot; Hernandez, Senior Advisor to the Administrator for Drug Prices, Centers for Medicare and Medicaid Services; and Acting Deputy General Counsel Beth Kelley of the Department of Health and Human Services. Mr. Doustdar referred to David Moore, executive vice president of U.S. operations, and Karsten Munk Knutsen, executive vice president and chief financial officer, Novo Nordisk. A reporter referred to former Vice President Richard B. Cheney, who died on November 3. The transcript was released by the Office of Communications on November 20.</note>
    <subject>
         <topic>Acetaminophen and other fever reducers</topic>
         <topic>Air traffic control system, improvement efforts</topic>
         <topic>Automobile industry, strengthening efforts</topic>
         <topic>Centers for Medicare and Medicaid</topic>
         <topic>China, trade with U.S.</topic>
         <topic>COVID–19 pandemic</topic>
         <topic>Critical minerals, supply chain improvements</topic>
         <topic>District of Columbia, law enforcement improvement efforts</topic>
         <topic>Election security and integrity, strengthening efforts</topic>
         <topic>Eli Lilly and Co.</topic>
         <topic>European Union, trade with U.S.</topic>
         <topic>Federal Government appropriations, lapse</topic>
         <topic>Federal programs, improvement efforts</topic>
         <topic>Food and Drug Administration</topic>
         <topic>Health insurance exchanges</topic>
         <topic>Illegal immigration</topic>
         <topic>India, Prime Minister</topic>
         <topic>India, relations with Pakistan</topic>
         <topic>Inflation</topic>
         <topic>Insulin cost controls</topic>
         <topic>Iran, Israeli airstrikes</topic>
         <topic>Israel, airstrikes on Iran</topic>
         <topic>Manufacturing industry, domestic investment</topic>
         <topic>Medicare and Medicaid programs</topic>
         <topic>Novo Nordisk</topic>
         <topic>Pakistan, relations with India</topic>
         <topic>Patient Protection and Affordable Care Act</topic>
         <topic>Pharmaceutical supply chains, improvement efforts</topic>
         <topic>Prescription drug costs, reduction efforts</topic>
         <topic>Secretary of Commerce</topic>
         <topic>Secretary of Health and Human Services</topic>
         <topic>Secretary of Transportation</topic>
         <topic>Senate filibuster</topic>
         <topic>Tariffs</topic>
         <topic>Tennessee, law enforcement improvement efforts in Memphis</topic>
         <topic>U.S. diplomatic efforts, expansion</topic>
         <topic>U.S. Immigration and Customs Enforcement</topic>
         <topic>Weight-loss drugs, costs and affordability</topic>
         <topic>White House Communications Director</topic>
         <geographic>
                    Washington, DC
                </geographic>
         <name>
              <namePart>Biden, Joseph R., Jr.</namePart>
        </name>
         <name>
              <namePart>Buttigieg, Peter P.M.</namePart>
        </name>
         <name>
              <namePart>Cheung, Steven</namePart>
        </name>
         <name>
              <namePart>Doustdar, Mike</namePart>
        </name>
         <name>
              <namePart>Duffy, Sean P.</namePart>
        </name>
         <name>
              <namePart>Emmer, Jacqueline</namePart>
        </name>
         <name>
              <namePart>Emmer, Thomas E., Jr.</namePart>
        </name>
         <name>
              <namePart>Kennedy, Robert F., Jr.</namePart>
        </name>
         <name>
              <namePart>Klomp, Christopher</namePart>
        </name>
         <name>
              <namePart>Lutnick, Howard W.</namePart>
        </name>
         <name>
              <namePart>Makary, Martin A.</namePart>
        </name>
         <name>
              <namePart>Mamdani, Zohran K.</namePart>
        </name>
         <name>
              <namePart>Manchin, Joseph A., III</namePart>
        </name>
         <name>
              <namePart>Modi, Narendra</namePart>
        </name>
         <name>
              <namePart>Obama, Barack</namePart>
        </name>
         <name>
              <namePart>Oz, Mehmet</namePart>
        </name>
         <name>
              <namePart>Pelosi, Nancy</namePart>
        </name>
         <name>
              <namePart>Ricks, David A.</namePart>
        </name>
         <name>
              <namePart>Sinema, Kyrsten L.</namePart>
        </name>
    </subject>
    <extension>
         <searchTitle>Remarks on Efforts To Reduce Prescription Drug Costs and an Exchange With Reporters;DCPD-202501101</searchTitle>
    </extension>
    <originInfo>
         <publisher>Office of the Federal Register, National Archives and Records Administration</publisher>
         <dateIssued encoding="w3cdtf">2025-11-06</dateIssued>
         <issuance>continuing</issuance>
         <frequency authority="marcfrequency">daily</frequency>
    </originInfo>
    <physicalDescription>
         <note type="source content type">deposited</note>
         <digitalOrigin>born digital</digitalOrigin>
         <extent>21 digital object pages</extent>
    </physicalDescription>
    <identifier type="uri">https://www.govinfo.gov/app/details/DCPD-202501101</identifier>
    <identifier type="local">P0b002ee1e230492c</identifier>
    <identifier type="ILS system id">000599742</identifier>
    <identifier type="Child ILS system id">000599742</identifier>
    <recordInfo>
         <recordContentSource authority="marcorg">DGPO</recordContentSource>
         <recordCreationDate encoding="w3cdtf">2026-05-28</recordCreationDate>
         <recordChangeDate encoding="w3cdtf">2026-05-28</recordChangeDate>
         <recordIdentifier source="DGPO">DCPD-202501101</recordIdentifier>
         <recordOrigin>machine generated</recordOrigin>
         <languageOfCataloging>
              <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
        </languageOfCataloging>
    </recordInfo>
    <accessCondition type="GPO scope determination">fdlp</accessCondition>
    <extension>
         <docClass>PRESDOC</docClass>
         <dcpdCategory>
                                
              <level1>Addresses and Remarks</level1>
                                
              <level2>Prescription drug costs, reduction efforts</level2>
                            
        </dcpdCategory>
         <dcpdCategory>
                                
              <level1>Interviews With the News Media</level1>
                                
              <level2>Exchanges with reporters, White House</level2>
                            
        </dcpdCategory>
         <location>
                                
              <name>Washington, DC</name>
                            
        </location>
         <name>Biden, Joseph R., Jr.</name>
         <name>Buttigieg, Peter P.M.</name>
         <name>Cheung, Steven</name>
         <name>Doustdar, Mike</name>
         <name>Duffy, Sean P.</name>
         <name>Emmer, Jacqueline</name>
         <name>Emmer, Thomas E., Jr.</name>
         <name>Kennedy, Robert F., Jr.</name>
         <name>Klomp, Christopher</name>
         <name>Lutnick, Howard W.</name>
         <name>Makary, Martin A.</name>
         <name>Mamdani, Zohran K.</name>
         <name>Manchin, Joseph A., III</name>
         <name>Modi, Narendra</name>
         <name>Obama, Barack</name>
         <name>Oz, Mehmet</name>
         <name>Pelosi, Nancy</name>
         <name>Ricks, David A.</name>
         <name>Sinema, Kyrsten L.</name>
         <subject>
                                
              <level1>Acetaminophen and other fever reducers</level1>
                            
        </subject>
         <subject>
                                
              <level1>Air traffic control system, improvement efforts</level1>
                            
        </subject>
         <subject>
                                
              <level1>Automobile industry, strengthening efforts</level1>
                            
        </subject>
         <subject>
                                
              <level1>Centers for Medicare and Medicaid</level1>
                            
        </subject>
         <subject>
                                
              <level1>China, trade with U.S.</level1>
                            
        </subject>
         <subject>
                                
              <level1>COVID–19 pandemic</level1>
                            
        </subject>
         <subject>
                                
              <level1>Critical minerals, supply chain improvements</level1>
                            
        </subject>
         <subject>
                                
              <level1>District of Columbia, law enforcement improvement efforts</level1>
                            
        </subject>
         <subject>
                                
              <level1>Election security and integrity, strengthening efforts</level1>
                            
        </subject>
         <subject>
                                
              <level1>Eli Lilly and Co.</level1>
                            
        </subject>
         <subject>
                                
              <level1>European Union, trade with U.S.</level1>
                            
        </subject>
         <subject>
                                
              <level1>Federal Government appropriations, lapse</level1>
                            
        </subject>
         <subject>
                                
              <level1>Federal programs, improvement efforts</level1>
                            
        </subject>
         <subject>
                                
              <level1>Food and Drug Administration</level1>
                            
        </subject>
         <subject>
                                
              <level1>Health insurance exchanges</level1>
                            
        </subject>
         <subject>
                                
              <level1>Illegal immigration</level1>
                            
        </subject>
         <subject>
                                
              <level1>India, Prime Minister</level1>
                            
        </subject>
         <subject>
                                
              <level1>India, relations with Pakistan</level1>
                            
        </subject>
         <subject>
                                
              <level1>Inflation</level1>
                            
        </subject>
         <subject>
                                
              <level1>Insulin cost controls</level1>
                            
        </subject>
         <subject>
                                
              <level1>Iran, Israeli airstrikes</level1>
                            
        </subject>
         <subject>
                                
              <level1>Israel, airstrikes on Iran</level1>
                            
        </subject>
         <subject>
                                
              <level1>Manufacturing industry, domestic investment</level1>
                            
        </subject>
         <subject>
                                
              <level1>Medicare and Medicaid programs</level1>
                            
        </subject>
         <subject>
                                
              <level1>Novo Nordisk</level1>
                            
        </subject>
         <subject>
                                
              <level1>Pakistan, relations with India</level1>
                            
        </subject>
         <subject>
                                
              <level1>Patient Protection and Affordable Care Act</level1>
                            
        </subject>
         <subject>
                                
              <level1>Pharmaceutical supply chains, improvement efforts</level1>
                            
        </subject>
         <subject>
                                
              <level1>Prescription drug costs, reduction efforts</level1>
                            
        </subject>
         <subject>
                                
              <level1>Secretary of Commerce</level1>
                            
        </subject>
         <subject>
                                
              <level1>Secretary of Health and Human Services</level1>
                            
        </subject>
         <subject>
                                
              <level1>Secretary of Transportation</level1>
                            
        </subject>
         <subject>
                                
              <level1>Senate filibuster</level1>
                            
        </subject>
         <subject>
                                
              <level1>Tariffs</level1>
                            
        </subject>
         <subject>
                                
              <level1>Tennessee, law enforcement improvement efforts in Memphis</level1>
                            
        </subject>
         <subject>
                                
              <level1>U.S. diplomatic efforts, expansion</level1>
                            
        </subject>
         <subject>
                                
              <level1>U.S. Immigration and Customs Enforcement</level1>
                            
        </subject>
         <subject>
                                
              <level1>Weight-loss drugs, costs and affordability</level1>
                            
        </subject>
         <subject>
                                
              <level1>White House Communications Director</level1>
                            
        </subject>
         <notes>The President spoke at 12:02 p.m. in the Oval Office at the White House. In his remarks, he referred to White House Communications Director Steven Cheung; former President Barack Obama; Jacqueline Emmer, wife of Rep. Emmer; former Secretary of Transportation Peter P.M. Buttigieg; and former Sens. Joseph A. Manchin III and Kyrsten L. Sinema. Administrator Oz referred to John Brooks, Deputy Administrator and Chief Policy and Regulatory Officer, and Inmaculada &quot;Inma&quot; Hernandez, Senior Advisor to the Administrator for Drug Prices, Centers for Medicare and Medicaid Services; and Acting Deputy General Counsel Beth Kelley of the Department of Health and Human Services. Mr. Doustdar referred to David Moore, executive vice president of U.S. operations, and Karsten Munk Knutsen, executive vice president and chief financial officer, Novo Nordisk. A reporter referred to former Vice President Richard B. Cheney, who died on November 3. The transcript was released by the Office of Communications on November 20.</notes>
         <accessId>DCPD-202501101</accessId>
         <president id="DJT" number="45" party="R" yearsInOffice="2017-2021">
                                
              <name type="authority-lnf">Trump, Donald J.</name>
                                
              <name type="authority-fnf">Donald J. Trump</name>
                                
              <name type="authority-other">Donald Trump</name>
                                
              <name type="authority-other">Donald John Trump</name>
                            
        </president>
    </extension>
</mods>